|
| 36938783 | Medical interpreter-mediated genetic counseling for Spanish preferring adults at risk for a hereditary cancer syndrome. | J Genet Couns | 2023 |
| 37590982 | Influenza Vaccination Among Pregnant People Before and During the Coronavirus Disease 2019 (COVID-19) Pandemic. | Obstet Gynecol | 2023 |
| 37644850 | Risk management actions following genetic testing in the Cancer Health Assessments Reaching Many (CHARM) Study: A prospective cohort study. | Cancer Med | 2023 |
| 37599140 | Simultaneous administration of mRNA COVID-19 bivalent booster and influenza vaccines. | Vaccine | 2023 |
| 37126135 | Evaluating cancer genetic services in a safety net system: overcoming barriers for a lasting impact beyond the CHARM research project. | J Community Genet | 2023 |
| 37470892 | Longitudinal adherence to breast cancer surveillance following cancer genetic testing in an integrated health care system. | Breast Cancer Res Treat | 2023 |
| 35144679 | Retrospective assessment of barriers and access to genetic services for hereditary cancer syndromes in an integrated health care delivery system. | Hered Cancer Clin Pract | 2022 |
| 35679147 | Risk-reducing surgery in unaffected individuals receiving cancer genetic testing in an integrated health care system. | Cancer | 2022 |
| 35707062 | Lessons learned and recommendations for data coordination in collaborative research: The CSER consortium experience. | HGG Adv | 2022 |
| 35436948 | Identifying patients with Lynch syndrome using a universal tumor screening program in an integrated healthcare system. | Hered Cancer Clin Pract | 2022 |
| 35689290 | Literacy-adapted, electronic family history assessment for genetics referral in primary care: patient user insights from qualitative interviews. | Hered Cancer Clin Pract | 2022 |
| 35522237 | ORCA, a values-based decision aid for selecting additional findings from genomic sequencing in adults: Efficacy results from a randomized trial. | Genet Med | 2022 |
| 36053287 | An accessible, relational, inclusive, and actionable (ARIA) model of genetic counseling compared with usual care: Results of a randomized controlled trial. | Genet Med | 2022 |
| 33754278 | Adaptation and early implementation of the PREdiction model for gene mutations (PREMM<sub>5</sub>â¿¢) for lynch syndrome risk assessment in a diverse population. | Fam Cancer | 2022 |
| 35123916 | Corrigendum to "Cancer Health Assessments Reaching Many (CHARM): A clinical trial assessing a multimodal cancer genetics services delivery program and its impact on diverse populations" [Contemporary Clinical Trials 106 (2021) 106432]. | Contemp Clin Trials | 2022 |
| 34906471 | Motivations and concerns of patients considering participation in an implementation study of a hereditary cancer risk assessment program in diverse primary care settings. | Genet Med | 2022 |
| 32981477 | Participant Reactions to a Literacy-Focused, Web-Based Informed Consent Approach for a Genomic Implementation Study. | AJOB Empir Bioeth | 2021 |
| 33549385 | Development and early implementation of an Accessible, Relational, Inclusive and Actionable approach to genetic counseling: The ARIA model. | Patient Educ Couns | 2021 |
| 34460173 | Impact of expanded carrier screening on health care utilization. | Am J Manag Care | 2021 |
| 34778694 | Systemic Barriers to Risk-Reducing Interventions for Hereditary Cancer Syndromes: Implications for Health Care Inequities. | JCO Precis Oncol | 2021 |
| 34834546 | Feasibility of a Traceback Approach for Using Pathology Specimens to Facilitate Genetic Testing in the Genetic Risk Analysis in Ovarian Cancer (GRACE) Study Protocol. | J Pers Med | 2021 |
| 33984519 | Cancer Health Assessments Reaching Many (CHARM): A clinical trial assessing a multimodal cancer genetics services delivery program and its impact on diverse populations. | Contemp Clin Trials | 2021 |
| 33191058 | A decision aid for additional findings in genomic sequencing: Development and pilot testing. | Patient Educ Couns | 2021 |
| 32033850 | Trivalent inactivated influenza vaccine (IIV3) during pregnancy and six-month infant development. | Vaccine | 2020 |
| 32089547 | Integrating stakeholder feedback in translational genomics research: an ethnographic analysis of a study protocol's evolution. | Genet Med | 2020 |
| 30670880 | Correction: Secondary findings from clinical genomic sequencing: prevalence, patient perspectives, family history assessment, and health-care costs from a multisite study. | Genet Med | 2019 |
| 31890059 | Recommended care and care adherence following a diagnosis of Lynch syndrome: a mixed-methods study. | Hered Cancer Clin Pract | 2019 |
| 31313633 | Consent for clinical genome sequencing: considerations from the Clinical Sequencing Exploratory Research Consortium. | Per Med | 2019 |
| 31068160 | Factors associated with recruitment, surveillance participation, and retention in an observational study of pregnant women and influenza. | BMC Pregnancy Childbirth | 2019 |
| 30729418 | Implementation of a Systematic Tumor Screening Program for Lynch Syndrome in an Integrated Health Care Setting. | Fam Cancer | 2019 |
| 30287922 | Secondary findings from clinical genomic sequencing: prevalence, patient perspectives, family history assessment, and health-care costs from a multisite study. | Genet Med | 2019 |
| 29293279 | Patient actions and reactions after receiving negative results from expanded carrier screening. | Clin Genet | 2018 |
| 30133189 | Approaches to carrier testing and results disclosure in translational genomics research: The clinical sequencing exploratory research consortium experience. | Mol Genet Genomic Med | 2018 |
| 30020962 | Assessment of willingness to pay for expanded carrier screening among women and couples undergoing preconception carrier screening. | PLoS One | 2018 |
| 30455898 | A case for expanding carrier testing to include actionable X-linked disorders. | Clin Case Rep | 2018 |
| 29423569 | Time Costs for Genetic Counseling in Preconception Carrier Screening with Genome Sequencing. | J Genet Couns | 2018 |
| 29754767 | Preconception Carrier Screening by Genome Sequencing: Results from the Clinical Laboratory. | Am J Hum Genet | 2018 |
| 29497922 | Why Patients Decline Genomic Sequencing Studies: Experiences from the CSER Consortium. | J Genet Couns | 2018 |
| 29733724 | Lessons Learned From A Study Of Genomics-Based Carrier Screening For Reproductive Decision Making. | Health Aff (Millwood) | 2018 |
| 29250907 | Patient perspectives on the use of categories of conditions for decision making about genomic carrier screening results. | Am J Med Genet A | 2018 |
| 27940182 | Design of a randomized controlled trial for genomic carrier screening in healthy patients seeking preconception genetic testing. | Contemp Clin Trials | 2017 |
| 28315134 | Reasons for Declining Preconception Expanded Carrier Screening Using Genome Sequencing. | J Genet Couns | 2017 |
| 28079899 | Genome sequencing and carrier testing: decisions on categorization and whether to disclose results of carrier testing. | Genet Med | 2017 |
| 28418800 | Predictors of Breastfeeding Initiation and Maintenance in an Integrated Healthcare Setting. | J Hum Lact | 2017 |
| 28944234 | The NextGen Study: patient motivation for participation in genome sequencing for carrier status. | Mol Genet Genomic Med | 2017 |
| 25880440 | Stakeholder perspectives on implementing a universal Lynch syndrome screening program: a qualitative study of early barriers and facilitators. | Genet Med | 2016 |
| 26889673 | Generating a taxonomy for genetic conditions relevant to reproductive planning. | Am J Med Genet A | 2016 |
| 26792268 | Patients' ratings of genetic conditions validate a taxonomy to simplify decisions about preconception carrier screening via genome sequencing. | Am J Med Genet A | 2016 |
| 26093606 | "Is It Worth Knowing?" Focus Group Participants' Perceived Utility of Genomic Preconception Carrier Screening. | J Genet Couns | 2016 |
| 25884995 | Systematic review of the predictive effect of MSI status in colorectal cancer patients undergoing 5FU-based chemotherapy. | BMC Cancer | 2015 |